Warner Financial Inc. lessened its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 21.1% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,605 shares of the exchange traded fund’s stock after selling 965 shares during the period. Warner Financial Inc.’s holdings in SPDR S&P Biotech ETF were worth $325,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Avior Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the period. Tidemark LLC increased its stake in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the period. Quintet Private Bank Europe S.A. purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at $40,000. ORG Wealth Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the third quarter worth $44,000. Finally, Howe & Rusling Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at about $49,000.
SPDR S&P Biotech ETF Price Performance
Shares of NYSEARCA XBI opened at $92.61 on Tuesday. The firm has a 50-day moving average of $93.35 and a 200 day moving average of $96.87. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The stock has a market cap of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- The 3 Best Retail Stocks to Shop for in August
- 3 Stocks Upgraded by Bank of America – Here’s Why They’re Bullish
- How to Calculate Stock Profit
- 2 Stocks to Benefit From China Tariff Resets: Is 60% a Bluff?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- High-Yield Texas Instruments Poised to Rebound in 2025
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.